Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty
- Conditions
- InfectionsAnkle Arthritis
- Interventions
- Drug: Intravenous VancomycinDrug: Intraosseous Vancomycin Injection
- Registration Number
- NCT06384651
- Lead Sponsor
- The Methodist Hospital Research Institute
- Brief Summary
The purpose of this study is to compare two different antibiotic regimens and techniques during total ankle arthroplasty (TAA).
Primary Objective: Comparable levels of vancomycin will be found in bone, soft tissue, and systemic samples between patient groups.
Secondary Objective: Compare 30 day and 90 day post-operative complication rates (infection) between the control (standard IV administration of vancomycin) vs the interventional group (intraosseous administration of vancomycin). The investigators hypothesize that there will be no difference in complication (infection) rates between groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 40
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intravenous Vancomycin Intravenous Vancomycin Patients will receive the orthopedic surgeon's standard of care pre-operative antibiotic regimen for TAA patients. This includes IV antibiotics (typically ancef or cefepime and vancomycin) will be started in the pre-operative period approximately 1 hour prior to incision (vancomycin dose weight-based at approximately 15mg/kg generally 1000-1750mg in 500mL normal saline (NS)) Intraosseous Vancomycin Intraosseous Vancomycin Injection IV antibiotics per physician's standard of care: Typically ancef or cefepime is started in pre-op within 1 hour of incision. IV Vancomycin will not be given preoperatively in this group. IO vancomycin is administered in the OR after sterile prep and draping has occurred (500mg in 100-150mL NS). IO Injection will take place into the medial malleolus.
- Primary Outcome Measures
Name Time Method Systemic Sample Vancomycin Tissue Concentration - End of Case perioperatively Systemic Sample Vancomycin Tissue Concentration - Start of Case perioperatively Capsule or Synovium Sample Vancomycin Tissue Concentration immediately after the procedure Talar Bone Sample Vancomycin Tissue Concentration immediately after the procedure Distal Tibia Sample Vancomycin Tissue Concentration immediately after the procedure
- Secondary Outcome Measures
Name Time Method 90 day post-operative wound complication and infection rates 90 days after the procedure
Trial Locations
- Locations (1)
Houston Methodist Hospital
🇺🇸Houston, Texas, United States